Effective melasma treatment with lasers relies on restraint, not power. The approach with the strongest track record is low-fluence Q-switched laser toning: repeated, gentle passes of a 1064nm Q-switched Nd:YAG beam that break down excess pigment a little at a time instead of blasting it in one aggressive session. Melasma reacts badly to heat and trauma, so the winning strategy is many light treatments rather than a few hard ones.
This guide explains why melasma is so stubborn, how laser toning works, which parameters matter, and how to choose a machine without buying rebound pigmentation for your clients.
Why is melasma so stubborn?
Melasma is stubborn because it is a chronic, relapse-prone condition driven by hormones and sunlight, not a one-off deposit of pigment you can simply remove. It shows up as symmetrical tan to brown patches on the cheeks, forehead, nose, and upper lip, and in most patients the excess melanin sits in the epidermis, the dermis, or both layers at once. That mixed depth is the core problem: a setting that clears surface pigment may miss deeper pigment, and a setting aggressive enough to reach the dermis can inflame the skin and make the melasma worse.
Two things follow from this. First, melasma tends to recur after treatment, so clinics should frame it as long-term management rather than a cure. Second, the triggers keep pushing pigment back: pregnancy, oral contraceptives, and sun exposure are all well-documented contributors. Any laser plan that ignores daily sun protection is building on sand.
Melasma is not a target you delete once. It is a tendency you manage. The laser lowers the pigment load; sunscreen and trigger control keep it down.
What is low-fluence Q-switched laser toning?
Laser toning is a technique that treats the whole affected area with a large-spot, low-energy 1064nm Q-switched beam over many sessions, rather than firing high-energy shots at individual spots. A Q-switched laser releases its energy in an ultra-short nanosecond pulse. In that instant the pigment absorbs the light and fragments through a photomechanical effect, and the debris is cleared by the body's phagocytes and lymphatic system. At low fluence, the goal is subtle, gradual clearance of excess melanin without the skin injury that provokes melasma to rebound.
The principle underneath all of this is selective photothermolysis, the idea that a correctly chosen wavelength and pulse duration can damage a target chromophore while sparing the surrounding tissue. It was defined by Anderson and Parrish in Science in 1983 and remains the foundation of every pigment laser sold today. Toning simply applies that principle at a deliberately gentle dose.
Why does 1064nm work for melasma?
The 1064nm wavelength works for melasma because it penetrates deep enough to reach dermal pigment while being absorbed by melanin more selectively than shorter, more superficial wavelengths. Longer wavelengths in the roughly 600 to 1200nm range sit in what is often called the optical window of skin, where light scatters less and travels deeper. That reach lets a 1064nm beam address the deeper melanin that makes melasma so hard to clear.
The alternative wavelength on most Q-switched Nd:YAG platforms, 532nm, is far more superficial and strongly absorbed at the surface. It can lift shallow, well-defined spots, but on melasma it carries a higher risk of inflaming the epidermis and triggering post-inflammatory hyperpigmentation (PIH). For melasma specifically, 1064nm at low fluence is the safer workhorse, with 532nm reserved for other lesions.
What parameters actually matter?
For melasma, the parameters that protect the skin matter more than the ones that maximize power. Large spot size, low fluence, and generous intervals between sessions are what keep toning safe. According to a 2022 systematic review by Lee and colleagues in Medicina, published protocols typically use a fluence around 1 to 3 J/cm2, a large spot size of roughly 6 to 10mm, and sessions spaced about one to two weeks apart, over roughly ten sessions.
| Approach | Fluence | Spot size | Interval | Melasma risk profile |
|---|---|---|---|---|
| Aggressive spot treatment | High | Small | Long | High: inflammation, PIH, rebound |
| Low-fluence toning (preferred) | Low (about 1 to 3 J/cm2) | Large (about 6 to 10mm) | 1 to 2 weeks | Lower, but hypopigmentation possible if overdone |
A practical session flows in this order:
- Consult, photograph the patient, and record baseline pigment and skin type.
- Cleanse and dry the treatment area; residual moisture wastes energy at the surface.
- Do a small test patch and start from low energy, watching how the skin responds before committing to full-face passes.
- Treat with a large spot and light, even passes; the clinical endpoint is subtle, not a strong reaction.
- Reinforce strict sun protection and book the next session one to two weeks out.
Starting low and testing first is not optional. Manufacturer guidance for Pmise Q-switched systems, including the 1064QCH, explicitly directs operators to begin at low energy with a few test shots and raise the dose only as the skin's response allows.
What about PIH and hypopigmentation?
The two failure modes to fear are post-inflammatory hyperpigmentation from treating too hard and mottled hypopigmentation from treating too much. Both are avoidable with discipline. The melasma reference material in our knowledge base warns that some patients develop obvious pigmentation after treatment and that relapse and pigment change are recognized complications, which is exactly why a small trial treatment on a 0.5 to 1cm2 area is advised before committing to a full protocol.
Overtreatment carries the opposite risk. The 2022 systematic review by Lee and colleagues in Medicina reports that mottled hypopigmentation, small pale spots that can be disfiguring, has been seen in roughly ten percent of East Asian patients in some series, with risk rising alongside higher cumulative energy and short intervals between sessions. The defenses are the same ones that make toning work in the first place: keep fluence low, keep the spot large, space sessions out, and stop before the skin is pushed too far. One fewer session is safer than one session too many.
Why melasma needs a combination approach
The laser is one lever, and on its own it rarely holds melasma down for long. The most durable results come from combining toning with topical and lifestyle measures that reduce pigment production and remove triggers. A workable clinic protocol pairs the device with the basics dermatology has relied on for years.
- Daily broad-spectrum sun protection, treated as non-negotiable rather than advice.
- Topical lightening agents used under professional supervision between sessions.
- Trigger review: hormonal contraceptives and heat exposure discussed with the patient.
- Realistic expectations set up front, framed as ongoing management with maintenance sessions.
- Consistent photography so faint gains and any early hypopigmentation are caught early.
Positioned this way, low-fluence 1064nm toning becomes the engine of a maintenance program rather than a magic bullet, which is how melasma is best handled.
How to choose a melasma treatment machine
Choose a machine that gives you fine control at the low end, a genuinely large spot, and dual wavelengths, because melasma is unforgiving of coarse, one-size-fits-all energy. On a capable Q-switched Nd:YAG platform you want small energy steps so you can dial in a gentle toning dose, an adjustable spot that reaches 6 to 10mm for even coverage, and both 1064nm and 532nm on hand so the same device can also address other pigment work. Short nanosecond pulse widths and a stable, uniform beam help fragment pigment cleanly at low energy.
Pmise builds several Q-switched Nd:YAG options around these needs. The compact MV8 and MV10 suit clinics that want a portable dual-wavelength toning workhorse, while the 1064QCH offers a larger articulated-arm system with a broad energy range and adjustable spot for busier practices. If you are still comparing device classes, our guides on how to choose a Q-switched Nd:YAG laser and long-pulse versus Q-switched Nd:YAG break down the trade-offs, and our full melasma treatment protocol walks through session planning.
Technical fit is only half the purchase. For a clinic buyer or distributor, the commercial terms decide whether a machine is safe to own for years, not just to demo. Work through this checklist before you sign.
- Regulatory compliance: confirm the device carries the approvals your market requires, such as CE marking for the EU or FDA clearance for the US, and request the registration and declaration-of-conformity documents. Ask the supplier to state the country of manufacture in writing.
- Warranty and spare parts: check the warranty length and coverage, and how long handpieces, optical components, and other wear parts stay available and at what price.
- After-sales and training: confirm remote and on-site technical support, operator and clinical training, and service documentation and parameter guidance in your language.
- Lead time and logistics: get realistic production and shipping timelines, plus spare-parts stock policy and installation support.
- OEM and distributor terms: if you resell, ask about MOQ, OEM branding options, distributor pricing, and territory support.
If low-fluence 1064nm toning fits your patient base, the next step is to match parameters, certifications, and budget to a specific platform. Contact the Pmise engineering team to request a configuration quote and spec sheet covering wavelengths, spot range, warranty, and the export documents your market requires.
Frequently Asked Questions
How many laser toning sessions does melasma need?
Most published low-fluence protocols run around ten sessions spaced one to two weeks apart, though the exact number varies by patient. Because melasma tends to relapse, clinics should plan for periodic maintenance rather than a fixed finish line. Improvement is gradual, so both the practitioner and the client need patience and consistent photography to judge progress fairly.
Is 1064nm or 532nm better for melasma?
For melasma, 1064nm at low fluence is the safer choice because it reaches deeper pigment while being gentler on the epidermis. The shorter 532nm wavelength is more superficial and more likely to inflame skin and trigger post-inflammatory hyperpigmentation on melasma-prone faces. Keep 532nm for other, well-defined superficial spots and use 1064nm toning as the melasma workhorse.
Can laser toning make melasma worse?
Yes, if it is done too aggressively. High fluence or short intervals can inflame the skin and provoke rebound hyperpigmentation, and excessive cumulative energy can cause mottled hypopigmentation. This is why low energy, a large spot, generous spacing, and a small test patch before full treatment all matter. Done with restraint, toning is generally regarded as effective and safe for melasma.
Does laser replace creams and sunscreen for melasma?
No. Laser toning lowers the pigment load, but sun protection and topical agents keep it down and address the triggers the laser cannot touch. The best outcomes come from combining the device with daily broad-spectrum sun protection, supervised topical lightening between sessions, and trigger review. Treating melasma as ongoing management, not a one-time procedure, is what produces lasting results.
Pmise Technical Team. Pmise manufactures Q-switched Nd:YAG and light-based aesthetic systems for clinics and distributors worldwide, with more than a decade of laser-device engineering behind our platforms.
